Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis

International Journal of Cardiology

Volumn 204, Issue , 2016, Pages 103-105

  Zhao, Jianping ^a   Liu, Tong ^a   Korantzopoulos, Panagiotis ^b   Letsas, Konstantinos P ^c   Zhang, Enyuan ^a   Yang, Yajuan ^a   Zhang, Zhiwei ^a   Qiu, Jiuchun ^a   Li, Jiao ^a   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Atrial fibrillation; Catheter ablation; Hyperuricemia; Meta analysis; Uric acid

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ARTICLE; ATRIAL FIBRILLATION; CATHETER ABLATION; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERURICEMIA; META ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; URIC ACID BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; COHORT ANALYSIS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; BIOMARKERS; CATHETER ABLATION; COHORT STUDIES; HUMANS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 84955241719     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.11.167     Document Type: Article

References (33)

1. P. Korantzopoulos, T.M. Kolettis, J.A. Goudevenos, and K. Siogas Errors and pitfalls in the non-invasive management of atrial fibrillation Int. J. Cardiol. 104 2005 125 130
2. B.P. Krijthe, A. Kunst, E.J. Benjamin, G.Y. Lip, O.H. Franco, A. Hofman, and et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur. Heart J. 4 2013 2746 2751
3. G.Y. Lip, H.F. Tse, and D.A. Lane Atrial fibrillation Lancet 379 2012 648 661
4. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int. J. Cardiol. 115 2007 135 143
5. Y.F. Hu, Y.J. Chen, Y.J. Lin, and S.A. Chen Inflammation and the pathogenesis of atrial fibrillation Nat. Rev. Cardiol. 12 2015 230 243
6. N. Wu, B. Xu, Y. Xiang, L. Wu, Y. Zhang, X. Ma, and et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis Int. J. Cardiol. 169 2013 62 72
7. T. Liu, L. Li, P. Korantzopoulos, J.A. Goudevenos, and G. Li Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation Am. J. Cardiol. 101 2008 1749 1752
8. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis J. Am. Coll. Cardiol. 49 2007 1642 1648
9. T. Liu, Q. Shao, S. Miao, E. Liu, G. Xu, R. Yuan, and et al. Red cell distribution width as a novel, inexpensive marker for paroxysmal atrial fibrillation Int. J. Cardiol. 171 2014 e52 e53
10. Z. Zhao, T. Liu, J. Li, W. Yang, E. Liu, and G. Li Elevated red cell distribution width level is associated with oxidative stress and inflammation in a canine model of rapid atrial pacing Int. J. Cardiol. 174 2014 174 176
11. K.L. Rock, H. Kataoka, and J.J. Lai Uric acid as a danger signal in gout and its comorbidities Nat. Rev. Rheumatol. 9 2013 13 23
12. G.K. Lantzounis, E.C. Tsimoyiannis, A.M. Kappas, and D.A. Galaris Uric acid and oxidative stress Curr. Pharm. Des. 11 2005 4145 4151
13. P. Strazzullo, and J.G. Puig Uric acid and oxidative stress: relative impact on cardiovascular Risk? Nutr. Metab. Cardiovasc. Dis. 17 2007 409 414
14. Y.L. Jin, T. Zhu, L. Xu, W.S. Zhang, B. Liu, C.Q. Jiang, and et al. Uric acid levels, even in the normal range, are associated with increased cardiovascular risk: the Guangzhou biobank cohort study Int. J. Cardiol. 168 2013 2238 2241
15. G. Levantesi, R.M. Marfisi, M.G. Franzosi, A.P. Maggioni, G.L. Nicolosi, C. Schweiger, and et al. Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction Int. J. Cardiol. 167 2013 262 269
16. A. Sciacqua, M. Perticone, E.J. Tassone, A. Cimellaro, S. Miceli, R. Maio, and et al. Uric acid is an independent predictor of cardiovascular events in post-menopausal women Int. J. Cardiol. 197 2015 271 275
17. Y. Yang, Y. Fan, J. Li, B. Liu, Y. Shao, H. Cao, and et al. Serum uric acid as a predictor for cardiovascular and all-cause mortality in women versus men Int. J. Cardiol. 185 2015 125 128
18. P. Korantzopoulos, K.P. Letsas, and T. Liu Xanthine oxidase and uric acid in atrial fibrillation Front. Physiol. 3 2012 150
19. Y. Koza Uric acid elevation in atrial fibrillation: is it simply an epiphenomenon or not? Int. J. Cardiol. 174 2014 869
20. K.P. Letsas, P. Korantzopoulos, G.S. Filippatos, C.C. Mihas, V. Markou, G. Gavrielatos, and et al. Uric acid elevation in atrial fibrillation Hell. J. Cardiol. 51 2010 209 213
21. T. Liu, X. Zhang, P. Korantzopoulos, S. Wang, and G. Li Uric acid levels and atrial fibrillation in hypertensive patients Intern. Med. 50 2011 799 803
22. T.F. Chao, C.L. Hung, S.J. Chen, K.L. Wang, T.J. Chen, Y.J. Lin, and et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation Int. J. Cardiol. 168 2013 4027 4032
23. X. Xiang, D. Na, W. Robin, G.W. Yan, and L.C. Shang Hyperuricemia is independently associated with increased risk of atrial fibrillation: a meta-analysis of cohort studies Int. J. Cardiol. 184 2015 699 702
24. K.P. Letsas, C.H. Siklody, P. Korantzopoulos, R. Weber, G. Burkle, C.C. Mihas, and et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation Int. J. Cardiol. 164 2013 94 98
25. X. Guo, S. Zhang, X. Yan, Y. Chen, R. Yu, D. Long, and et al. Postablation neutrophil/lymphocyte ratio correlates with arrhythmia recurrence after catheter ablation of lone atrial fibrillation Chin. Med. J. 127 2014 1033 1038
26. X.N. He, S.N. Li, J.L. Zhan, S.L. Xie, Z.J. Zhang, J.Z. Dong, and et al. Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation Chin. Med. J. 126 2013 860 864
27. U. Canpolat, K. Aytemir, H. Yorgun, L. Sahiner, E.B. Kaya, S. Cay, and et al. Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation Europace 16 2014 1731 1737
28. R.P. Harris, M. Helfand, S.H. Woolf, K.N. Lohr, C.D. Mulrow, S.M. Teutsch, and et al. Current methods of the US Preventive Services Task Force: a review of the process Am. J. Prev. Med. 20 2001 21 35
29. M. Levine, S. Walter, H. Lee, T. Haines, A. Holbrook, and V. Moyer Users' guides to the medical literature. IV. How to use an article about harm. Evidence-based medicine working group JAMA 271 1994 1615 1619
30. T.F. Chao, H.M. Tsao, Y.J. Lin, C.F. Tsai, W.S. Lin, S.L. Chang, and et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up Circ. Arrhythm. Electrophysiol. 5 2012 514 520
31. T.F. Chao, K. Ambrose, H.M. Tsao, Y.J. Lin, S.L. Chang, L.W. Lo, and et al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation Heart Rhythm. 9 2012 1185 1191
32. F. Ouyang, R. Tilz, J. Chun, B. Schmidt, E. Wissner, T. Zerm, and et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up Circulation 122 2010 2368 2377
33. R.R. Tilz, A. Rillig, A.M. Thum, A. Arya, P. Wohlmuth, A. Metzner, and et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy J. Am. Coll. Cardiol. 60 2012 1921 1929